Based in Rochester, Minnesota, Cytotheryx is developing a revolutionary platform technology to increase the supply of available liver cells to advance research and change lives. Currently, a limited quantity of primary human hepatocytes are available in the market for use in drug discovery and disease-specific research. Our platform bio-incubator technology allows us to significantly increase the supply and quality of liver cells, allowing for a new gold standard in toxicology and metabolic studies in drug discovery and changing the world of liver disease research and medicine. By expanding access to high-quality, reliable cells, we’re opening doors for how we develop therapeutics, treat liver disease, advanced biomedical research, and beyond.